Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell CarcinomaNew England Journal of MedicineFebruary 16, 201910.1056/nejmoa1816047Cited by 2,550SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis